Results 121 to 130 of about 23,640 (157)
Some of the next articles are maybe not open access.

CMT

2013
openaire   +2 more sources

CMT-COVID Survey

Clinical Medical Case Reports and Reviews, 2022
openaire   +1 more source

CMT

2009
Nils Peters   +199 more
openaire   +1 more source

CMT 73 26021

2021
Ranasinghe, Gerard   +2 more
openaire   +1 more source

CMT

Neurology Today, 2003
openaire   +1 more source

CMT-3. CollaGenex.

Current opinion in investigational drugs (London, England : 2000), 2004
CMT-3 is an orally active matrix metalloprotease inhibitor, and one of a series of inhibitors of multiple proteases and cytokines, under development by CollaGenex. The compound is currently undergoing phase II trials for the potential treatment of cancer, in particular metastatic cancer and HIV-related Kaposi's sarcoma.
openaire   +1 more source

Leukoencephalopathy and conduction blocks in PLEKHG5-associated intermediate CMT disease

Neuromuscular Disorders, 2021
Bruno Francou   +2 more
exaly  

CMT

2011
openaire   +1 more source

CMT

2006
openaire   +1 more source

Microstructure and mechanical properties of 6061/7N01 CMT+P joints

Journal of Materials Processing Technology, 2019
Shengsun Hu, Junqi Shen
exaly  

Home - About - Disclaimer - Privacy